title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Monday,20220418T154044,https://www.benzinga.com/news/22/04/26669813/stocks-that-hit-52-week-lows-on-monday,SCYX,0.005428,Neutral,0.012332
"Earnings Scheduled For May 12, 2022",20220512T085523,https://www.benzinga.com/news/earnings/22/05/27156592/earnings-scheduled-for-may-12-2022,SCYX,0.017681,Neutral,-0.128992
Stocks That Hit 52-Week Lows On Monday,20220425T160100,https://www.benzinga.com/markets/options/22/04/26791205/52-weeks-high-and-low-article,SCYX,0.008154,Neutral,-0.012034
Stocks That Hit 52-Week Lows On Thursday,20220421T175401,https://www.benzinga.com/markets/options/22/04/26742233/52-weeks-high-and-low-article,SCYX,0.021637,Neutral,-0.001819
"Silence Therapeutics  ( NASDAQ:SLN ) , Alnylam Pharmaceuticals  ( NASDAQ:ALNY ) , Eli Lilly  ( NYSE:LLY ) , Amryt Pharma  ( NASDAQ:AMYT ) , SCYNEXIS  ( NASDAQ:SCYX ) , SINTX Technologies  ( NASDAQ:SINT ) , Ocuphire Pharma  ( NASDAQ:OCUP ) , Regeneron Pharmaceuticals  ( NASDAQ:REGN ) , VistaGen Therapeutics  ( NASDAQ:VTGN ) , Axsome Therapeutics  ( NASDAQ:AXSM ) , Lyra Therapeutics  ( NASDAQ:LYRA ) , Revance Therapeutics  ( NASDAQ:RVNC )  - Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary",20220908T221721,https://www.benzinga.com/general/biotech/22/09/28804732/important-biotech-catalysts-for-september-8-2022-end-of-the-day-summary,SCYX,0.132611,Neutral,0.132503
"Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know - iShares Biotechnology ETF  ( NASDAQ:IBB ) , BondBloxx ETF Trust BondBloxx BB-Rated USD High Yield Corporate Bond ETF  ( ARCA:XBB ) ",20221101T200154,https://www.benzinga.com/general/biotech/22/11/29508633/provention-bios-second-try-apelliss-eye-disorder-drug-review-3-adcom-verdicts-and-more-novembers-,SCYX,0.062761,Neutral,0.0
Stocks That Hit 52-Week Lows On Friday,20220422T162629,https://www.benzinga.com/markets/options/22/04/26764450/52-weeks-high-and-low-article,SCYX,0.012589,Neutral,0.003683
